rs143123053

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001164507.2(NEB):​c.2603T>C​(p.Leu868Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00116 in 1,614,038 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L868L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 18 hom. )

Consequence

NEB
NM_001164507.2 missense

Scores

2
9
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 3.97

Publications

9 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.030873865).
BP6
Variant 2-151687453-A-G is Benign according to our data. Variant chr2-151687453-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 465592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00103 (157/152354) while in subpopulation EAS AF = 0.01 (52/5188). AF 95% confidence interval is 0.00785. There are 0 homozygotes in GnomAd4. There are 99 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 18 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.2603T>C p.Leu868Pro missense_variant Exon 27 of 182 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.2603T>C p.Leu868Pro missense_variant Exon 27 of 182 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.2603T>C p.Leu868Pro missense_variant Exon 27 of 182 5 NM_001164508.2 ENSP00000380505.3 P20929-2
NEBENST00000427231.7 linkc.2603T>C p.Leu868Pro missense_variant Exon 27 of 182 5 NM_001164507.2 ENSP00000416578.2 P20929-3
NEBENST00000409198.5 linkc.2603T>C p.Leu868Pro missense_variant Exon 27 of 150 5 ENSP00000386259.1 P20929-4

Frequencies

GnomAD3 genomes
AF:
0.00103
AC:
157
AN:
152236
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.0100
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00621
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00156
AC:
389
AN:
249214
AF XY:
0.00132
show subpopulations
Gnomad AFR exome
AF:
0.0000646
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00467
Gnomad EAS exome
AF:
0.00812
Gnomad FIN exome
AF:
0.00562
Gnomad NFE exome
AF:
0.000301
Gnomad OTH exome
AF:
0.00215
GnomAD4 exome
AF:
0.00117
AC:
1716
AN:
1461684
Hom.:
18
Cov.:
31
AF XY:
0.00119
AC XY:
867
AN XY:
727120
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.0000224
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00459
AC:
120
AN:
26136
East Asian (EAS)
AF:
0.0223
AC:
886
AN:
39698
South Asian (SAS)
AF:
0.00101
AC:
87
AN:
86256
European-Finnish (FIN)
AF:
0.00517
AC:
276
AN:
53402
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.000249
AC:
277
AN:
1111848
Other (OTH)
AF:
0.00104
AC:
63
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
102
204
307
409
511
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00103
AC:
157
AN:
152354
Hom.:
0
Cov.:
32
AF XY:
0.00133
AC XY:
99
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41578
American (AMR)
AF:
0.00
AC:
0
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3472
East Asian (EAS)
AF:
0.0100
AC:
52
AN:
5188
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4824
European-Finnish (FIN)
AF:
0.00621
AC:
66
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68034
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00119
Hom.:
0
Bravo
AF:
0.000631
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000720
AC:
6
ExAC
AF:
0.00149
AC:
180
Asia WGS
AF:
0.00722
AC:
25
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nemaline myopathy 2 Benign:3
Jan 07, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 03, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 25, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25296583, 25589043) -

Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NEB: BS2 -

Nemaline myopathy 2;C5543431:Arthrogryposis multiplex congenita 6 Benign:1
Jun 28, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Uncertain
0.080
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.12
.;.;T;.;T;.;.
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.85
D;D;D;D;D;.;.
M_CAP
Benign
0.062
D
MetaRNN
Benign
0.031
T;T;T;T;T;T;T
MetaSVM
Benign
-0.83
T
MutationAssessor
Uncertain
2.1
M;M;.;M;M;M;M
PhyloP100
4.0
PrimateAI
Uncertain
0.73
T
PROVEAN
Uncertain
-2.5
N;N;.;N;N;.;.
REVEL
Uncertain
0.35
Sift
Benign
0.030
D;T;.;T;D;.;.
Sift4G
Uncertain
0.0020
D;D;D;D;D;D;D
Polyphen
0.98
.;.;.;.;D;.;.
Vest4
0.96
MVP
0.71
MPC
0.42
ClinPred
0.052
T
GERP RS
5.5
Varity_R
0.74
gMVP
0.59
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143123053; hg19: chr2-152543967; API